The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals

Liver International

Volumn 36, Issue 2, 2016, Pages 275-283

  Fukuda, Takuya ^a   Hamaguchi, Masahide ^a   Kojima, Takao ^b   Hashimoto, Yoshitaka ^a   Ohbora, Akihiro ^b   Kato, Takahiro ^c   Nakamura, Naoto ^a   Fukui, Michiaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b ASAHI UNIVERSITY   (Japan)

^c Aiseikai Yamashina Hospital   (Japan)

Author keywords

Cohort study; Diabetes; Epidemiology; Liver disease; Non alcoholic fatty liver

Indexed keywords

ADULT; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; QUESTIONNAIRE; RETROSPECTIVE STUDY; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC IMAGING; JAPAN; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; JAPAN; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84955489581     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12912     Document Type: Article

References (37)

1. Hamaguchi M, Kojima T, Takeda N, etal. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-8.
2. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-61.
3. Chitturi S, Wong VW-S, Farrell G. Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground. JGastroenterol Hepatol 2011; 26(Suppl. 1): 163-72.
4. Hamaguchi M, Takeda N, Kojima T, etal. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol 2012; 18: 1508-16.
5. Jimba S, Nakagami T, Takahashi M, etal. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005; 22: 1141-5.
6. Shibata M, Kihara Y, Taguchi M, etal. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007; 30: 2940-4.
7. Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 2010; 10: 306-15.
8. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes 2012; 3: 110-7.
9. Arase Y, Suzuki F, Ikeda K, etal. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. J Gastroenterol 2009; 44: 1064-70.
10. Sung K-C, Jeong W-S, Wild SH, Byrne CD. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. Diabetes Care 2012; 35: 717-22.
11. Park SK, Seo MH, Shin HC, Ryoo J-H. Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. Hepatology 2013; 57: 1378-83.
12. Margariti E, Deutsch M, Manolakopoulos S, Papatheodoridis GV. Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. Ann Gastroenterol 2012; 25: 45.
13. Eguchi Y, Hyogo H, Ono M, etal. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012; 47: 586-95.
14. Kwon Y-M, Oh S-W, Hwang S, etal. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol 2012; 107: 1852-8.
15. Chon CW, Kim BS, Cho YK, etal. Effect of nonalcoholic fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men. Gut Liv 2012; 6: 368-73.
16. Sinn DH, Gwak G-Y, Park HN, etal. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am J Gastroenterol 2012; 107: 561-7.
17. Schwartz KL, Monsur JC, Bartoces MG, etal. Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study. BMC Fam Pract 2005; 6: 28.
18. Hamaguchi M, Kojima T, Ohbora A, etal. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012; 18: 156-67.
19. Hamaguchi M, Kojima T, Itoh Y, etal. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-15.
20. Matsuo S, Imai E, Horio M, etal. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92.
21. Chitturi S, Farrell GC, Hashimoto E, etal. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-87.
22. Aaron DJ, Kriska AM, Dearwater SR, etal. Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am J Epidemiol 1995; 142: 191-201.
23. Ryu S, Chang Y, Kim D-I, etal. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 2007; 53: 71-7.
24. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. International Diabetes Institute, Health Communications Australia Pty. Ltd, 2000. Available at http://www.wpro.who.int/nutrition/documents/Redefining_obesity/en/. Accessed 10 March 2015.
25. Anuurad E, Shiwaku K, Nogi A, etal. The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. JOccup Health 2003; 45: 335-43.
26. Yang J, Shiwaku K, Nabika T, etal. High frequency of cardiovascular risk factors in overweight adult Japanese subjects. Arch Med Res 2007; 38: 337-44.
27. Hsu WC, Araneta MRG, Kanaya AM, etal. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care 2014; 38: 150-8.
28. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34(Suppl. 1): S11-61.
29. Funatogawa I, Funatogawa T, Nakao M, etal. Changes in body mass index by birth cohort in Japanese adults: results from the National Nutrition Survey of Japan 1956-2005. Int J Epidemiol 2009; 38: 83-92.
30. Kushiyama A, Yoshida Y, Kikuchi T, etal. Twenty-year trend of increasing obesity in young patients with poorly controlled type 2 diabetes at first diagnosis in urban Japan. J Diabetes Investig 2013; 4: 540-5.
31. Spalding KL, Arner E, Westermark PO, etal. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783-7.
32. Byrne CD. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Diabet Med 2012; 29: 1098-107.
33. Huang-Doran I, Sleigh A, Rochford JJ, etal. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 2010; 207: 245-55.
34. Cheung O, Sanyal AJ. Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 2009; 25: 230-7.
35. Jin Y-J, Kim KM, Hwang S, etal. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol 2012; 27: 1341-7.
36. Klimentidis YC, Chen Z, Arora A, Hsu C-H. Association of physical activity with lower type 2 diabetes incidence is weaker among individuals at high genetic risk. Diabetologia 2014; 57: 2530-4.
37. Sasazuki S, Inoue M, Tsuji I, etal. Body mass index and mortality from all causes and major causes in Japanese: results of a pooled analysis of 7 large-scale cohort studies. J Epidemiol 2011; 21: 417-30.